SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-21-012177
Filing Date
2021-06-16
Accepted
2021-06-16 14:06:37
Documents
2
Period of Report
2021-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 2322
2 POWER OF ATTORNEY suejeanlinpoa.htm EX-24.1 7605
  Complete submission text file 0001567619-21-012177.txt   11438
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Issuer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARCUTIS BIOTHERAPEUTICS, INC. 3027 TOWNSGATE ROAD, SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address
LIN SUE-JEAN (Reporting) CIK: 0001867788 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39186 | Film No.: 211021215